- AU$8.58bn
- AU$8.60bn
- AU$2.35bn
Brief: Cochlear Declares Final Dividend A$1.75 Per Share
Brief: Cochlear Sees FY24 Underlying Net Profit Between A$355 Mln And A$375 Mln
Brief: UK's CMA Gives Notice Of Proposal To Accept Final Undertakings On Cochlear/Oticon Merger
Australian healthcare stocks remained unmoved in first half of 2023
Australia's Cochlear falls after UK blocks part of Oticon Medical purchase
Brief: Cochlear Says UK CMA Published Final Report On Acquisition Of Oticon Medical
Brief: UK competition watchdog blocks Cochlear/Demant deal
Competition and Mkts - Merger Update - Cochlear Limited/Oticon Medical
'The consumer medical technologies', Bernstein starts hearing and dental products makers
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
UK watchdog says Cochlear's Oticon Medical deal could harm market (updated)
Brief: Cochlear Disagrees With CMA's Findings On Proposed Oticon Medical Acquisition
UK watchdog says Cochlear's Oticon takeover can hurt competition (updated)
UK watchdog says Cochlear's Oticon purchase can hurt competition
Brief: UK Watchdog Provisionally Finds Hearing Implants Cochlear/Oticon Deal May Hurt Competition
Competition and Mkts - Merger Update: Cochlear Limited / Oticon Medical
Cochlear, Demant contest UK regulator's Oticon deal concerns
Brief: UK's CMA Says Demant,Cochlear Believe No Realistic Prospect Of Substantial Lessening Of Competition From Deal